Related Experiment Video
Updated: Dec 20, 2025

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events
1Directs the Center for Population-Level Bioethics at Rutgers University and is the Henry Rutgers professor of bioethics in the Department of Health Behavior, Society and Policy at Rutgers School of Public Health and in the Department of Philosophy at Rutgers's School of Arts and Sciences.
Abstract:
Human challenge trials to test the efficacy of vaccine candidates against SARS-CoV-2, the novel coronavirus behind Covid-19, could save considerable time and many lives. But they may initially seem unethical because they expose healthy volunteers to a live virus that is killing many people and for which no cure exists. This article argues that this is not the correct test of their ethics. The correct test is comparative. And in the special circumstances of the Covid-19 pandemic, human challenge trials meet the correct test better than standard efficacy testing would.
Insights
Human challenge trials for SARS-CoV-2 vaccines are ethical. Comparing them to standard testing, these trials offer a faster, more effective way to save lives during the COVID-19 pandemic.
Area of Science:
- Infectious Diseases
- Vaccinology
- Bioethics
Background:
- The COVID-19 pandemic necessitated rapid vaccine development against SARS-CoV-2.
- Human challenge trials (HCTs) involve intentionally exposing volunteers to a pathogen.
- Ethical concerns often arise regarding HCTs due to volunteer risk without proven treatments.
Purpose of the Study:
- To evaluate the ethical justification of SARS-CoV-2 vaccine human challenge trials.
- To propose a comparative ethical framework for assessing HCTs.
- To argue that HCTs are ethically superior to standard efficacy testing in specific pandemic contexts.
Main Methods:
- Ethical analysis of human challenge trials versus traditional vaccine efficacy studies.
- Comparative assessment of risks, benefits, and societal value.
- Consideration of the unique circumstances presented by the COVID-19 pandemic.
Main Results:
- Standard ethical tests may initially deem HCTs problematic due to volunteer exposure.
- A comparative ethical analysis reveals HCTs can be ethically justifiable.
- In the context of COVID-19, HCTs demonstrate greater ethical merit than standard testing.
Conclusions:
- Human challenge trials for COVID-19 vaccines are ethically sound when evaluated comparatively.
- HCTs offer a more efficient pathway for vaccine development, saving time and lives.
- The specific context of the pandemic strengthens the ethical case for employing HCTs.
More Related Videos
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence studies: Biowaivers
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Ethics in Research
Clinical Trials: Overview
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...